Common use of PTO Clause in Contracts

PTO. During the Term, the Executive is eligible to earn up to four weeks of paid-time-off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s policies and procedures relating to PTO.

Appears in 4 contracts

Sources: Employment Agreement (Esperion Therapeutics, Inc.), Employment Agreement (Esperion Therapeutics, Inc.), Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is shall be eligible to earn up to for at least four (4) weeks of paid-time-paid time off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of ) per year in accordance with the Company’s policies and procedures relating in effect from time to PTOtime for its senior vice presidents generally. Executive may carry over up to one (1) week of unused PTO into the next following year only.

Appears in 3 contracts

Sources: Employment Agreement (Vallon Pharmaceuticals, Inc.), Employment Agreement (Vallon Pharmaceuticals, Inc.), Employment Agreement (Vallon Pharmaceuticals, Inc.)

PTO. During the Term, the Executive is shall be eligible to earn up to for at least four (4) weeks of paid-time-paid time off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of ) per year in accordance with the Company’s 's policies and procedures relating in effect from time to PTOtime.

Appears in 3 contracts

Sources: Employment Agreement (GRI BIO, Inc.), Employment Agreement (Vallon Pharmaceuticals, Inc.), Employment Agreement (Vallon Pharmaceuticals, Inc.)

PTO. During the TermEmployment Period, the Executive is will be eligible to earn up to four weeks of for paid-time-off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of ) in accordance with the Company’s policies and procedures relating policies, as may be in effect from time to PTOtime, for its senior executives generally; provided that Executive will be entitled to PTO at a rate of no less than four (4) weeks per calendar year (pro-rated for partial calendar years). Executive will use such PTO at such reasonable time or times each year as he may determine after consultation with the Chairman of the Board.

Appears in 2 contracts

Sources: Employment Agreement (SharpLink Gaming, Inc.), Employment Agreement (SharpLink Gaming, Inc.)

PTO. During the Term, the Executive is eligible to earn accrue up to four (4) weeks of paid-time-off (“PTO”)) per year, to be accrued on a pro rata basis and subject to the terms and conditions of in accordance with the Company’s policies and procedures relating to PTOPTO and may be amended from time to time.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the TermEmployment Period, the Executive is will be eligible to earn up to four weeks of for paid-time-off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of ) in accordance with the Company’s policies and procedures relating policies, as may be in effect from time to PTOtime, for its senior executives generally; provided that Executive will be entitled to PTO at a rate of no less than four (4) weeks per calendar year (pro-rated for partial calendar years). Executive will use such PTO at such reasonable time or times each year as he may determine after consultation with the Chief Executive Officer.

Appears in 1 contract

Sources: Employment Agreement (SharpLink Gaming, Inc.)

PTO. During the Term, the Executive is eligible to earn up to four five (5) weeks of paid-time-off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s policies and procedures relating to PTO.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is eligible to earn accrue up to four (4) weeks of paid-time-off (“PTO”)) per year, to be accrued on a pro rata basis and subject to the terms and conditions of accrual, eligibility and, in accordance with the Company’s policies and procedures relating to PTOPTO and may be amended from time to time.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is eligible to earn up to four (4) weeks of paid-time-paid time off (“PTO”)) per calendar year, to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s policies and procedures relating to PTO, which may be amended from time to time.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is eligible to earn up to four five weeks of paid-time-off timeoff ("PTO"), to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s 's policies and procedures relating to PTO.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is eligible to earn up to four five weeks of paid-time-off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s policies and procedures relating to PTO.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)

PTO. During the Term, the Executive is shall be eligible to earn up to for at least four (4) weeks of paid-time-paid time off (“PTO”), to be accrued on a pro rata basis and subject to the terms and conditions of ) per year in accordance with the Company’s 's policies and procedures relating in effect from time to PTOtime. Executive may carry over up to one (1) week of unused PTO into the next following year only.

Appears in 1 contract

Sources: Employment Agreement (Vallon Pharmaceuticals, Inc.)

PTO. During the Term, the Executive is eligible to earn up to four (4) weeks of paid-time-paid time off (“PTO”), ) to be accrued on a pro rata basis and subject to the terms and conditions of the Company’s policies and procedures relating to PTOPTO and may be amended from time to time.

Appears in 1 contract

Sources: Employment Agreement (Esperion Therapeutics, Inc.)